Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Programmed Cell Death 1 Ligand 1(PDL1, PD-L1)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT04902040
What this trial is testing

Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies

Who this might be right for
Advanced Bladder CarcinomaAdvanced Lung Non-Small Cell CarcinomaAdvanced Malignant Solid Neoplasm+32 more
M.D. Anderson Cancer Center 19
Testing effectiveness (Phase 2)Looking for participantsNCT06492408
What this trial is testing

Neoadjuvant Intra-tumor Double Immunotherapy for Hepatocellular Carcinoma.

Who this might be right for
Hepatic CancerSurgery
Second Affiliated Hospital of Guangzhou Medical University 90
Large-scale testing (Phase 3)Active Not RecruitingNCT02453282
What this trial is testing

Phase III Open Label First Line Therapy Study of MEDI 4736 (Durvalumab) With or Without Tremelimumab Versus SOC in Non Small-Cell Lung Cancer (NSCLC)

Who this might be right for
Non-Small-Cell Lung Carcinoma NSCLC
AstraZeneca 1,118
Large-scale testing (Phase 3)Study completedNCT02973789
What this trial is testing

Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure (LUNAR)

Who this might be right for
Nonsmall Cell Lung CancerNSCLC
NovoCure GmbH 291
Large-scale testing (Phase 3)Ended earlyNCT04740918
What this trial is testing

Trastuzumab Emtansine in Combination With Atezolizumab or Placebo as a Treatment for Participants With Human Epidermal Growth Factor 2 (HER2)-Positive and Programmed Death-ligand 1 (PD-L1)-Positive Locally Advanced (LABC) or Metastatic Breast Cancer (MBC)

Who this might be right for
Metastatic Breast Cancer
Hoffmann-La Roche 96
Testing effectiveness (Phase 2)Ended earlyNCT03081923
What this trial is testing

Durvalumab Alone or With Tremelimumab in Refractory Germ Cell Tumors

Who this might be right for
Germ Cell Tumor
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 36
Early research (Phase 1)WithdrawnNCT02871323
What this trial is testing

Durvalumab in Treating Patients With Primary, Post-Polycythemia Vera, or Post-Essential Thrombocythemia Myelofibrosis

Who this might be right for
Polycythemia Vera, Post-Polycythemic Myelofibrosis PhasePrimary Myelofibrosis
Northwestern University
Early research (Phase 1)Ended earlyNCT04060342
What this trial is testing

GB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic AdenocarcinomaEsophageal AdenocarcinomaEsophageal Squamous Cell Carcinoma+11 more
GB006, Inc., a wholly owned subsidiary of Gossamer Bio, Inc. 61
Testing effectiveness (Phase 2)Ended earlyNCT04150562
What this trial is testing

Avelumab (Bavencio) With IL-15 in Subjects With Clear-Cell Renal Carcinoma

Who this might be right for
Clear-Cell Renal Carcinoma
National Cancer Institute (NCI) 2
Not applicableUnknownNCT05879796
What this trial is testing

Envafolimab Combined With Endostar and Concurrent Chemoradiotherapy for Locally Advanced Primary Cervical Cancer

Who this might be right for
Cervical Cancer
Peking University Third Hospital 30
Testing effectiveness (Phase 2)Ended earlyNCT04469725
What this trial is testing

KN046 (a Humanized PD-L1/CTLA4 Bispecific Single Domain Fc Fusion Protein Antibody) in Subjects With Thymic Carcinoma

Who this might be right for
Thymic Carcinoma
Jiangsu Alphamab Biopharmaceuticals Co., Ltd 95
Early research (Phase 1)Study completedNCT02738489
What this trial is testing

Evaluate the Safety and Tolerability of Using the SHR-1210 in Patients With Advanced Melanoma

Who this might be right for
Advanced Melanoma
Jiangsu HengRui Medicine Co., Ltd. 36
Not applicableUnknownNCT05228808
What this trial is testing

Immunohistochemical Expression of PD-L1 in Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Adenocarcinoma
Sohag University 50
Testing effectiveness (Phase 2)Study completedNCT02725489
What this trial is testing

Pilot Study of Durvalumab and Vigil in Advanced Women's Cancers

Who this might be right for
Breast CancerOvarian CancerFallopian Tube Cancer+4 more
Mary Crowley Medical Research Center 13
Testing effectiveness (Phase 2)Ended earlyNCT04428047
What this trial is testing

Evaluation of Bintrafusp Alfa in Operable and Untreated Head and Neck Squamous Cell Carcinoma

Who this might be right for
Squamous Cell Carcinoma of Head and Neck
UNICANCER 7
Testing effectiveness (Phase 2)UnknownNCT05151549
What this trial is testing

Carilizumab Combined With Concurrent Chemoradiotherapy

Who this might be right for
Cervical Cancer
Hunan Cancer Hospital 46
Early research (Phase 1)Ended earlyNCT05069935
What this trial is testing

FT538 in Combination With Monoclonal Antibodies in Advanced Solid Tumors

Who this might be right for
Solid Tumor, Adult
Fate Therapeutics 16
Testing effectiveness (Phase 2)Looking for participantsNCT06918132
What this trial is testing

Cemiplimab and Fianlimab Before Surgery for the Treatment of Stage IB-IIIB Non-Small Cell Lung Cancer

Who this might be right for
Lung Non-Small Cell CarcinomaStage IB Lung Cancer AJCC v8Stage II Lung Cancer AJCC v8+2 more
Mayo Clinic 60
Large-scale testing (Phase 3)Study completedNCT02425891
What this trial is testing

Atezolizumab in Combination With Nab-Paclitaxel Compared With Placebo With Nab-Paclitaxel for Participants With Previously Untreated Metastatic Triple-Negative Breast Cancer (IMpassion130)

Who this might be right for
Triple Negative Breast Cancer
Hoffmann-La Roche 902
Early research (Phase 1)UnknownNCT05008861
What this trial is testing

Gut Microbiota Reconstruction for NSCLC Immunotherapy

Who this might be right for
Non-Small Cell Lung Cancer
Shanghai Zhongshan Hospital 20
Next Page